Cold Agglutinin Disease

Bibliography

  1. Acikgoz, O., Bayramgil, A., Cavusoglu, G., & Sadri, S. (2021). Rare side effect caused by atezolizumab, an immune checkpoint inhibitor: Cold agglutinin disease. Journal of Oncology Pharmacy Practice: Official Publication of the International Society of Oncology Pharmacy Practitioners, 27(8), 2066–2068. https://doi.org/10.1177/10781552211033009
  2. Atiq, O., Atiq, S. O., Atiq, Z. O., Patel, V., Atiq, M. O., & Atiq, O. T. (2020). Pembrolizumab-Induced Cold Agglutinin Disease. The American Journal of Case Reports, 21, e924283. https://doi.org/10.12659/AJCR.924283
  3. Berentsen, S. (2016). Cold agglutinin disease. Hematology: The American Society of Hematology Education Program, 2016(1), 226–231.
  4. Berentsen, S. (2020). New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia. Frontiers in Immunology, 11, 590. https://doi.org/10.3389/fimmu.2020.00590
  5. Berentsen, S. (2021). How I treat cold agglutinin disease. Blood, 137(10), 1295–1303. https://doi.org/10.1182/blood.2019003809
  6. Berentsen, S., Barcellini, W., D'Sa, S., & Jilma, B. (2022). Sutimlimab for treatment of cold agglutinin disease: Why, how and for whom? Immunotherapy, 14(15), 1191–1204. https://doi.org/10.2217/imt-2022-0085
  7. Berentsen, S., Barcellini, W., D'Sa, S., Randen, U., Tvedt, T. H. A., Fattizzo, B., Haukås, E., Kell, M., Brudevold, R., Dahm, A. E. A., Dalgaard, J., Frøen, H., Hallstensen, R. F., Jæger, P. H., Hjorth-Hansen, H., Małecka, A., Oksman, M., Rolke, J., Sekhar, M., … Tjønnfjord, G. E. (2020). Cold agglutinin disease revisited: A multinational, observational study of 232 patients. Blood, 136(4), 480–488. https://doi.org/10.1182/blood.2020005674
  8. Berentsen, S., Fattizzo, B., & Barcellini, W. (2023). The choice of new treatments in autoimmune hemolytic anemia: How to pick from the basket? Frontiers in Immunology, 14, 1180509. https://doi.org/10.3389/fimmu.2023.1180509
  9. Berentsen, S., Tjønnfjord, G. E., Brudevold, R., Gjertsen, B. T., Langholm, R., Løkkevik, E., Sørbø, J. H., & Ulvestad, E. (2001). Favourable response to therapy with the anti-CD20 monoclonal antibody rituximab in primary chronic cold agglutinin disease. British Journal of Haematology, 115(1), 79–83. https://doi.org/10.1046/j.1365-2141.2001.03078.x
  10. Berentsen, S., Ulvestad, E., Langholm, R., Beiske, K., Hjorth-Hansen, H., Ghanima, W., Sørbø, J. H., & Tjønnfjord, G. E. (2006). Primary chronic cold agglutinin disease: A population based clinical study of 86 patients. Haematologica, 91(4), 460–466.
  11. Bhattacharyya, J., Mihara, K., Takihara, Y., & Kimura, A. (2012). Successful treatment of IgM-monoclonal gammopathy of undetermined significance associated with cryoglobulinemia and cold agglutinin disease with immunochemotherapy with rituximab, fludarabine, and cyclophosphamide. Annals of Hematology, 91(5), 797–799. https://doi.org/10.1007/s00277-011-1322-0
  12. Broome, C. M. (2023). Complement-directed therapy for cold agglutinin disease: Sutimlimab. Expert Review of Hematology, 16(7), 479–494. https://doi.org/10.1080/17474086.2023.2218611
  13. Christenson, W. N., Dacie, J. V., Croucher, B. E. E., & Charlwood, P. A. (1957). Electrophoretic Studies on Sera containing High-Titre Cold Haemagglutinins: Identification of the Antibody as the Cause of an Abnormal γ Peak. British Journal of Haematology, 3(3), 262–273. https://doi.org/10.1111/j.1365-2141.1957.tb05795.x
  14. Clough, M. C., & Richter, I. M. (1918). A study of an autoagglutinin occurring in a human serum. Johns Hopkins Hosp Bull, 29, 86.
  15. Cunha, B. A., & Pherez, F. M. (2009). Mycoplasma pneumoniae community-acquired pneumonia (CAP) in the elderly: Diagnostic significance of acute thrombocytosis. Heart & Lung: The Journal of Critical Care, 38(5), 444–449. https://doi.org/10.1016/j.hrtlng.2008.10.005
  16. Donath, J., & Landsteiner, K. (1904). Über paroxysmale Hämoglobinurie. Münchener medizinische Wochenschrift, 51, 1590–1593.
  17. Evans, R. S., Baxter, E., & Gilliland, B. C. (1973). Chronic Hemolytic Anemia Due to Cold Agglutinins: A 20-Year History of Benign Gammopathy With Response to Chlorambucil. Blood, 42(3), 463–470. https://doi.org/10.1182/blood.V42.3.463.463
  18. Gelbenegger, G., Berentsen, S., & Jilma, B. (2023). Monoclonal antibodies for treatment of cold agglutinin disease. Expert Opinion on Biological Therapy, 23(5), 395–406. https://doi.org/10.1080/14712598.2023.2209265
  19. Gertz, M. A. (2022). Updates on the Diagnosis and Management of Cold Autoimmune Hemolytic Anemia. Hematology/Oncology Clinics of North America, 36(2), 341–352. https://doi.org/10.1016/j.hoc.2021.11.001
  20. Hippe, E., Jensen, K. B., Olesen, H., Lind, K., & Thomsen, P. E. B. (1970). Chlorambucil Treatment of Patients With Cold Agglutinin Syndrome. Blood, 35(1), 68–72. https://doi.org/10.1182/blood.V35.1.68.68
  21. Horstmann, D. M., & Tatlock, H. (1943). COLD AGGLUTININS: A DIAGNOSTIC AID IN CERTAIN TYPES OF PRIMARY ATYPICAL PNEUMONIA. Journal of the American Medical Association, 122(6), 369–370. https://doi.org/10.1001/jama.1943.72840230003006a
  22. Ito, S., Wang, D., Purcell, A., Chetlapalli, K., Lee, A. I., Cuker, A., & Goshua, G. (2023). Cost-Effectiveness of Sutimlimab Versus Standard-of-Care in Transfusion Dependent Patients with Primary Cold Agglutinin Disease in the United States. Blood, 142(Supplement 1), 2316. https://doi.org/10.1182/blood-2023-187270
  23. Jacobs, J. W., Booth, G. S., Woo, J. S., Adkins, B. D., & Stephens, L. D. (2024). How the United States syphilis epidemic may portend a resurgence of an unusual hematologic condition: The connection between syphilis and paroxysmal cold hemoglobinuria. American Journal of Hematology, 99(3), 484–485. https://doi.org/10.1002/ajh.27190
  24. Jäger, U., D'Sa, S., Schörgenhofer, C., Bartko, J., Derhaschnig, U., Sillaber, C., Jilma-Stohlawetz, P., Fillitz, M., Schenk, T., Patou, G., Panicker, S., Parry, G. C., Gilbert, J. C., & Jilma, B. (2019). Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: A first-in-human trial. Blood, 133(9), 893–901. https://doi.org/10.1182/blood-2018-06-856930
  25. Jain, M. D., Cabrerizo-Sanchez, R., Karkouti, K., Yau, T., Pendergrast, J. M., & Cserti-Gazdewich, C. M. (2013). Seek and you shall find--but then what do you do? Cold agglutinins in cardiopulmonary bypass and a single-center experience with cold agglutinin screening before cardiac surgery. Transfusion Medicine Reviews, 27(2), 65–73. https://doi.org/10.1016/j.tmrv.2012.12.001
  26. Kanthack, A. A., Durham, H. E., & Blandford, W. F. H. (1898). On Nagana, or Tsetse Fly Disease. (Report, Made to the Tsetse Fly Committee of the Royal Society, of Observations and Experiments Carried out from November, 1896, to August, 1898). Proceedings of the Royal Society of London, 64, 100–118.
  27. Khwaja, J., Japzon, N., Gabriel, M., Raju, K., Rajaratnam, V., Gupta, R., Rismani, A., Kyriakou, C., & D'Sa, S. (2024). Cold agglutinin disease and cryoglobulinaemia: A frequent coexistence with clinical impact. British Journal of Haematology, 204(2), e21–e24. https://doi.org/10.1111/bjh.19185
  28. Landsteiner, K. (1903). Über Beziehungen zwischen dem Blutserum und den Körperzellen. Münchener medizinische Wochenschrift, 50, 1812–1814.
  29. Lee, E. J., & Kueck, B. (1998). Rituxan in the Treatment of Cold Agglutinin Disease. Blood, 92(9), 3490–3491. https://doi.org/10.1182/blood.V92.9.3490
  30. LUBINSKI, H., & GOLDBLOOM, A. (1946). ACUTE HEMOLYTIC ANEMIA ASSOCIATED WITH AUTOAGGLUTINATION WITH A THERMAL AMPLITUDE OF 0 TO 37 C. American Journal of Diseases of Children, 72(3), 325–333. https://doi.org/10.1001/archpedi.1946.02020320076009
  31. Mbaya, A., Kumshe, H., & Okwudiri, C. (2012). The Mechanisms of Anaemia in Trypanosomosis: A Review. In D. Silverberg (Ed.), Anemia. InTech. https://doi.org/10.5772/29530
  32. McCOMBS, R. P., & McELROY, J. S. (1937). REVERSIBLE AUTOHEMAGGLUTINATION WITH PERIPHERAL VASCULAR SYMPTOMS. Archives of Internal Medicine, 59(1), 107–117. https://doi.org/10.1001/archinte.1937.00170170113007
  33. Nelson, R. (2023). Syphilis rates soar in the USA amid penicillin shortage. The Lancet, 402(10401), 515. https://doi.org/10.1016/S0140-6736(23)01665-3
  34. Olesen, H. (1964). CHLORAMBUCIL TREATMENT IN THE COLD AGGLUTININ SYNDROME. Scandinavian Journal of Haematology, 1, 116–128. https://doi.org/10.1111/j.1600-0609.1964.tb00010.x
  35. Rossi, G., Gramegna, D., Paoloni, F., Fattizzo, B., Binda, F., D'Adda, M., Farina, M., Lucchini, E., Mauro, F. R., Salvi, F., Marchetti, M., Fazi, P., Zaja, F., & Barcellini, W. (2018). Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: A phase 2 prospective GIMEMA study. Blood, 132(5), 547–550. https://doi.org/10.1182/blood-2018-03-835413
  36. Röth, A., Barcellini, W., D'Sa, S., Miyakawa, Y., Broome, C. M., Michel, M., Kuter, D. J., Jilma, B., Tvedt, T. H. A., Fruebis, J., Jiang, X., Lin, S., Reuter, C., Morales-Arias, J., Hobbs, W., & Berentsen, S. (2021). Sutimlimab in Cold Agglutinin Disease. New England Journal of Medicine, 384(14), 1323–1334. https://doi.org/10.1056/NEJMoa2027760
  37. Röth, A., Barcellini, W., D'Sa, S., Miyakawa, Y., Broome, C. M., Michel, M., Kuter, D. J., Jilma, B., Tvedt, T. H. A., Weitz, I. C., Yoo, R., Jayawardene, D., Vagge, D. S., Kralova, K., Shafer, F., Wardȩcki, M., Lee, M., & Berentsen, S. (2023). Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease. American Journal of Hematology, 98(8), 1246–1253. https://doi.org/10.1002/ajh.26965
  38. Röth, A., Barcellini, W., Tvedt, T. H. A., Miyakawa, Y., Kuter, D. J., Su, J., Jiang, X., Hobbs, W., Arias, J. M., Shafer, F., & Weitz, I. C. (2022). Sutimlimab improves quality of life in patients with cold agglutinin disease: Results of patient-reported outcomes from the CARDINAL study. Annals of Hematology, 101(10), 2169–2177. https://doi.org/10.1007/s00277-022-04948-y
  39. Röth, A., Berentsen, S., Barcellini, W., D'Sa, S., Jilma, B., Michel, M., Weitz, I. C., Yamaguchi, M., Nishimura, J., Vos, J. M. I., Storek, M., Wong, N., Patel, P., Jiang, X., Vagge, D. S., Wardęcki, M., Shafer, F., Lee, M., & Broome, C. M. (2022). Sutimlimab in patients with cold agglutinin disease: Results of the randomized placebo-controlled phase 3 CADENZA trial. Blood, 140(9), 980–991. https://doi.org/10.1182/blood.2021014955
  40. Röth, A., Broome, C. M., Barcellini, W., Tvedt, T. H. A., Miyakawa, Y., D'Sa, S., Cella, D., Bozzi, S., Jayawardene, D., Yoo, R., Shafer, F., Wardęcki, M., & Weitz, I. C. (2023). Long-term sutimlimab improves quality of life for patients with cold agglutinin disease: CARDINAL 2-year follow-up. Blood Advances, 7(19), 5890–5897. https://doi.org/10.1182/bloodadvances.2022009318
  41. Ruzickova, S., Pruss, A., Odendahl, M., Wolbart, K., Burmester, G.-R., Scholze, J., Dörner, T., & Hansen, A. (2002). Chronic lymphocytic leukemia preceded by cold agglutinin disease: Intraclonal immunoglobulin light-chain diversity in V(H)4-34 expressing single leukemic B cells. Blood, 100(9), 3419–3422. https://doi.org/10.1182/blood.V100.9.3419
  42. Schubothe, H. (1966). The cold hemagglutinin disease. Seminars in Hematology, 3(1), 27–47.
  43. Steverding, D. (2008). The history of African trypanosomiasis. Parasites & Vectors, 1, 3. https://doi.org/10.1186/1756-3305-1-3
  44. Swiecicki, P. L., Hegerova, L. T., & Gertz, M. A. (2013). Cold agglutinin disease. Blood, 122(7), 1114–1121. https://doi.org/10.1182/blood-2013-02-474437
22 / 22